ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Navid Sadeghi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7786-8786; OpenAlex author ID A5008905848. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 1 paper

Papers 1

Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-11-2994 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

James L. Abbruzzese · 1 shared paper, 2012 · strength 0.04
- Paper Metformin use is associated with better survival of diabetic patients with pancreatic cancer. DOI 10.1158/1078-0432.ccr-11-2994 ↗
Manal M. Hassan · 1 shared paper, 2012 · strength 0.04
- Paper Metformin use is associated with better survival of diabetic patients with pancreatic cancer. DOI 10.1158/1078-0432.ccr-11-2994 ↗
Donghui Li · 1 shared paper, 2012 · strength 0.04
- Paper Metformin use is associated with better survival of diabetic patients with pancreatic cancer. DOI 10.1158/1078-0432.ccr-11-2994 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.